Company intelligence / Profile preview

TWI Chem

Taipei City, Taiwanpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~21
Development stage: Preclinical

Overview

TWi Pharmaceuticals focuses on developing and commercializing high-barrier niche generic drugs primarily for the US market. Recent product launches include testosterone topical solution and guanfacine HCl tablets. The company has received multiple ANDA approvals from the US FDA in recent years. TWi Biotechnology develops new drugs targeting innate immunity-related diseases such as diabetes mellitus and gout, but specific clinical results are not detailed in search results.

Therapeutic areas: OtherImmunology
Modalities: Small molecules (focus on generics and new drugs)
Industry: Biotech

Drug pipeline

1 asset

OX14

Pre-clinical

Indications: Bone resorption disorders, Multiple myeloma, Osteoporosis, Paget's disease

Partnerships

Not explicitly listed in search results. Strategic partnerships mentioned generally by both entities but without specifics

Beyond the preview

Go deeper on TWI Chem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TWI Chem.

Explore the full profile